Fig. 4
From: BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
LncRNA expression in cancer cells. a MALAT-1 expression in luminal (MCF-7 and T-47D) and triple negative breast cancer (MDA-231: MDA-MB-231) cell lines. MALAT-1 RNA was tested to determine the level of expression of this abundant lncRNA used as positive control. MALAT-1 is a nuclear lncRNA. b LncEPCAM/BC200 expression in luminal and triple negative breast cancer cell lines. LncEPCAM/BC200 is both nuclear and cytoplasmic. All images were taken at 400x magnification